Noopept for cognitive impairment after ischemic stroke
Comparison in people · 2011
- What was studied
- 60 participants who had experienced ischemic stroke within the prior 12 months. 30 received Noopept and 30 did not. All completed the study.
- Main finding
- In an open 60-person comparison, the authors reported greater MMSE improvement and better categorical fluency with Noopept after two months. Clock-drawing scores did not differ significantly.
Reported findings and study design
Open prospective comparison. The average time since stroke was 6.14 months in the active group and 6.83 months in controls. Outcomes included MMSE, drawing, verbal associations and clinician-rated change.
Population or model 60 participants who had experienced ischemic stroke within the prior 12 months. 30 received Noopept and 30 did not. All completed the study.
Dose, route and schedule
10 mg Noopept orally twice daily after meals for two months. Both groups continued indicated antihypertensive, antiplatelet and lipid-lowering therapy.
Protocol source ↗ · Original Russian article text and indexed English abstract. Numerical image tables were not independently transcribed.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| MMSE at 2 months | Both groups improved. Improvement was greater with Noopept. | Reported statistically significant between-group comparison |
| Categorical verbal associations | Improved in the Noopept arm | The article reports a significant change. |
| Clock drawing and modified Rankin Scale | No significant between-group differences reported | |
| Completion and reported tolerability | 60/60 completed | The authors reported no significant adverse reactions. |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- The open design and concomitant care limit causal interpretation. Exact tabulated effects require legible original tables.
- The 12 months in the abstract refer to the window for previous stroke. The treatment course lasted two months.
Related publications may describe some of the same participants or experiments.
Source details
Original Russian article text and indexed English abstract. Numerical image tables were not independently transcribed.
Sources checked
Citation
A. V. Amelin, A. Yu. Ilyukhina, A. A. Shmonin. Noopept for cognitive impairment after ischemic stroke Korsakov Journal of Neurology and Psychiatry. 2011;111(10):44–46. PMID 22500312.